Bay Street News, May, 2024

PARIS and CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) — NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a […]

Outcome from End-of-Phase 2 Meeting Supportive of a Placebo-Controlled Phase 3 Trial Updated 12 and 24-Month Data from Phase 2 […]

– Observed encouraging complete response (CR) rates as of the February 1, 2024, data cutoff in previously untreated HR-MDS and […]

SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) — Synaptics® Incorporated (Nasdaq: SYNA) today announced Ken Rizvi will join the […]

Vincerx continued to progress Phase 1 dose-escalation studies for VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC), and VIP236, a […]

SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) — Firsthand Technology Value Fund, Inc. (OTCQB: SVVC) (the “Fund”), a publicly […]

BOSTON, May 14, 2024 (GLOBE NEWSWIRE) — Zapata Computing Holdings Inc. (“Zapata AI” or the “Company”) (Nasdaq: ZPTA), the Industrial […]

SANTA CLARA, Calif., May 14, 2024 (GLOBE NEWSWIRE) — Today, AMD (NASDAQ: AMD) announced the following events for the financial […]

Hauppauge, NY, May 14, 2024 (GLOBE NEWSWIRE) — – Cemtrex Inc. (NASDAQ: CETX, CETXP), an advanced security technology and industrial services […]

Live webcast on Thursday, May 16that 4:00 PM ET THE WOODLANDS, TX, May 14, 2024 (GLOBE NEWSWIRE) — Autonomix Medical, […]